Wednesday, 8 July 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 8 July 2026
IQVIA
IQVIA
Red carpet win for cheeky campaign

A humorous campaign for a serious disease has won this Big Pharma a global award at a prestigious event considered the industry's 'Oscars'.

2 complete responses in 4 weeks
More astonishing success as trial logs two complete responses in a month for blood cancer patients that had previously failed therapy
TODAY
GM gone, successor named
Yet another company has announced the departure of its General Manager, with a replacement already named
TODAY
Klick
Klick
J&J to pull drug worldwide
The US pharma giant has confirmed the long-standing treatment will be removed from the Australian market this year
7 July
Revenue soars 25% on broad listing
Patients and prescribers have wasted no time embracing the broad listing of immunotherapies, with use jumping straight away
7 July
Who's been named GM... again?
Two years after stepping away from a GM role this executive is back at the top working for a new company
6 July
Blockbusters stuck in PBS limbo
Seven drugs recommended in March have been marked 'inactive' including two of the world's up-and-coming top-sellers
6 July
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (24)

Access & Reimbursement (1)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (11)

Extra leave coming to pharma?
Gen Z already makes up a third of the workforce and they already hold a crucial bargaining chip in workplace negotiations
TODAY
Another drug leaving Australia
'Commercial changes' and 'commercial viability' given as the reasons behind this company's decision to cease supply
TODAY
Company lands its biggest buy ever
Shells out $14B to expand its therapeutic footprint and it's snagged a drug that's already exceeding sales forecasts
TODAY
Novartis buys Aussie-backed firm
Pays more than $2 billion for an ADC biotech backed by Australian venture capital firm Brandon Capital
7 July
New FY brings fresh career start
The new financial year kicks off with a round of job moves including promotions, departures and retirements
7 July
Drug dropped from PBAC meeting
A new treatment will now be considered at a future PBAC meeting, with a pending TGA decision likely the reason
7 July
Gene genius: Aussies nab awards
Four Australian companies have picked up prizes at the Asia Pacific Cell & Gene Therapy Excellence Awards. Find out who
6 July
MSAC delivers a No over price
Blow after Committee dishes a rejection saying it was unable to discern if this drug 'was good value for money'
6 July
Novartis hit with first generic
The first copycat of Novartis' drug and a new high strength of Ozempic are among a long list of medicines approved
6 July Approvals Action
Pharma Wonderland opens in Sydney
$250 million plant expected to become one of the largest pharmaceutical manufacturing facilities in the Southern Hemisphere
3 July
Where next for six Country Heads?
ICYMI: Some of industry's biggest names are between jobs. Find out who plus the other most popular stories this week
3 July Your Week in 5 Minutes
Pharmas cut spend on patients
The latest MA transparency report reveals pharma's financial support to patient organisations, has dropped year-on-year
3 July
Haemophilia market heats up
A pegged blockbuster has been approved by the TGA with the company 'working with urgency' to ensure equitable access
3 July
Gamechanger stumps cost experts
Worth the cost? Nobody knows and patients are missing out because health systems can't accurately assess its cost-effectiveness
3 July
Swipe/NEXT
Swipe/NEXT
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.